Head & Brain Injury Advice and Resources

Blog

U.S. Army Invests in Research on New Chemical Compound to Treat TBI

A new orally active, chemical compound called Posiphen is now being investigated by a small company in Pennsylvania called QR Pharma, Inc. Its CEO Dr. Maria Maccecchini says that research on mice shows the compound crosses the blood-brain barrier and inhibits synthesis of the three neuro-toxic proteins known to cause Alzheimer’s disease. In

Read More